@article{3031620,
    title = "Randomized phase III trial on niraparib - TSR-042 (dostarlimab) vs
physician's choice CHEmotherapy in recurrent ovarian, fallopian tube or
primary peritoneal cancer patients not candidate for platinum
retreatment: NItCHE trial (MITO 33)",
    author = "Lorusso, D. and Musacchio, L. and Pignata, S. and Braicu, E. I. and and Cibula, D. and Colombo, N. and Frenel, J-S. and Zagouri, F. and Carbone, and V. and Ghizzoni, V. and Giolitto, S. and Giudice, E. and Landolfo, C. and and Perri, M. T. and Ricci, C. and Salutari, V. and Scambia, G.",
    journal = "Annals of Oncology",
    year = "2021",
    volume = "32",
    number = "5",
    pages = "S768-S769",
    publisher = "Elsevier",
    issn = "0923-7534, 1569-8041",
    doi = "10.1016/j.annonc.2021.08.1258"
}